More articles from Review

Open Access
Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapy
Sifan Li, Chang Che, Yelu Zhou, Daiming Fan, Xue Bai, Yuanyuan Lu and Xiaodi Zhao

Cancer Biology & Medicine January 2026, 20250347; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0347
Open Access
Innovative cross-intervention: copper ions and metabolic pathways in cancer therapy
Lili Niu, Wei Su, Lixia Ju, Jun Xiang, Zhou Yang and Bing Yao

Cancer Biology & Medicine January 2026, 20250198; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0198
Open Access
Current status of traditional Chinese medicine in modulating mitochondrial metabolic abnormalities in tumors
Siyi Ma, Jiarong Li, Bingjie Hao and Lihong Fan

Cancer Biology & Medicine December 2025, 22 (12) 1439-1454; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0246
Open Access
Harnessing the power of cancer-associated fibroblasts to revolutionize pancreatic cancer treatment
Jian Shen, Ruopu Wu, Tao Yin, Qun Wang and Lei Nie

Cancer Biology & Medicine December 2025, 22 (12) 1473-1492; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0288
Open Access
Primary cilia in cancer: structures, functions, mechanisms, and therapeutic implications
Miaomiao Zheng, Jun Zhou and Yijie Wang

Cancer Biology & Medicine December 2025, 22 (12) 1455-1472; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0340
Open Access
From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management
Junnan Xu, Kun Fang, Xiaoxi Li, Li Han, Shulan Sun and Tao Sun

Cancer Biology & Medicine December 2025, 22 (12) 1493-1514; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0431
Open Access
Current status of management of immune-related adverse events and practical needs for oncologist education
Binhe Tian, Yuanmei Yang, Shuman Kuang, Mingjian Piao, Chengjie Li, Haitao Zhao and Hanping Wang

Cancer Biology & Medicine December 2025, 22 (12) 1515-1536; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0346
Open Access
Neutrophil extracellular traps and metabolic reprogramming in renal cell carcinoma: implications for tumor progression and immune-based therapeutics
Asif Shahzad, Yueli Ni, Zhuoran Teng, Wenjing Liu, Honggang Bai, Yijian Sun, Kun Cui, Qiuxin Duan, Xiangjie Liu, Zhe Xu, Jinshan Zhang, Jiaojiao Xia, Rong Che, Ting Guo, Zhe Yang and Qiao Zhang

Cancer Biology & Medicine November 2025, 22 (11) 1282-1303; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0219
Open Access
Biological mechanism and immune response of MHC-II expression in tumor cells
Mengya Zhou, Siwei Pan, Yanqiang Zhang, Can Hu and Zhiyuan Xu

Cancer Biology & Medicine November 2025, 22 (11) 1304-1326; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0248
Open Access
Research progress and challenges in the treatment of oncogene-addicted non-small cell lung cancer
Hanyi Li, Xuanguang Li, Tong Li, Fan Ren, Haochuan Yu, Dianxun Fu, Zuoqing Song and Song Xu

Cancer Biology & Medicine November 2025, 22 (11) 1353-1371; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0153

Main menu

User menu

Search

More articles from Review

Pages

Navigate

More Information

For Authors

Journal Services